39 results
8-K
EX-99.1
fm225ixzgh7t6
9 Aug 22
Viracta Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates
8:30am
8-K
EX-99.1
5inj7giu
5 Nov 21
Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and Oxford Finance
9:00am
8-K
9lirv96fy5mvfal
16 Aug 21
Viracta Therapeutics Announces the Appointment of Flavia Borellini, Ph.D., and Jane F. Barlow, M.D., MPH, MBA, to its Board of Directors
4:45pm
8-K
EX-99.1
u23yt4bdg3c
16 Aug 21
Viracta Therapeutics Announces the Appointment of Flavia Borellini, Ph.D., and Jane F. Barlow, M.D., MPH, MBA, to its Board of Directors
4:45pm
424B3
agi2 w1ojqqgmehtlo9
14 Jan 21
Prospectus supplement
5:11pm
S-4/A
dlk0c18ec zzwxkvne
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm